Pancreatic Cancer Research

ResearcherSendai Medical CenterActive in the last 2 years

Yoshihide Kanno

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2044-5483; OpenAlex author ID A5080519941. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 9

  1. Detection of an intraductal component of a pancreatic ductal adenocarcinoma using a novel ultrathin pancreatoscope. Co-author DOI 10.1055/a-2914-7399↗
  2. Large-diameter Plastic Stents as An Option for Preoperative Biliary Drainage for Patients with Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy. First author DOI 10.4166/kjg.2026.033↗
  3. Pancreatic Ductal Adenocarcinoma Concomitant with Main Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Case Report. Co-author DOI 10.12659/ajcr.932565↗
  4. Efficacy of EUS-guided celiac plexus neurolysis compared with medication alone for unresectable pancreatic cancer in the oxycodone/fentanyl era: a prospective … Co-author DOI 10.1016/j.gie.2020.01.011↗
  5. [Detection of small pancreatic cancer during surveillance of the main pancreatic duct stenosis]. Co-author DOI 10.11405/nisshoshi.116.99↗
  6. Predictive Value of Localized Stenosis of the Main Pancreatic Duct for Early Detection of Pancreatic Cancer. Co-author DOI 10.5946/ce.2019.018↗
  7. Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Stud… Co-author DOI 10.1158/2326-6066.cir-17-0386↗
  8. Vascular image in autoimmune pancreatitis by contrast-enhanced color-Doppler endoscopic ultrasonography: Comparison with pancreatic cancer. Co-author DOI 10.4103/2303-9027.129519↗
  9. [Pancreatic tumor: progress in diagnosis and treatment. Topics: I. Pancreatic carcinoma; 3. Differential diagnosis of pancreatic cancer]. Co-author DOI 10.2169/naika.101.17↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toshitaka Sakai · 5 shared papers, 2019–2026 · strength 0.90
  2. Keisuke Yonamine · 4 shared papers, 2019–2026 · strength 0.78
  3. Kei Ito · 2 shared papers, 2026 · strength 0.60
  4. Kei Ito · 7 shared papers, 2012–2021 · strength 0.52
  5. Kaori Masu · 5 shared papers, 2012–2020 · strength 0.35
  6. Toji Murabayashi · 3 shared papers, 2019–2020 · strength 0.28
  7. Takaho Okada · 3 shared papers, 2019–2021 · strength 0.28
  8. Hidehito Sumiya · 1 shared paper, 2026 · strength 0.26
  9. Takashi Tsuchiya · 1 shared paper, 2021 · strength 0.11
  10. Yuki Fujii · 1 shared paper, 2019 · strength 0.08
  11. Go Kobayashi · 2 shared papers, 2012–2014 · strength 0.07
  12. Masanori Kon · 1 shared paper, 2018 · strength 0.06
  13. Hiroaki Yanagimoto · 1 shared paper, 2018 · strength 0.06
  14. Mari S. Oba · 1 shared paper, 2018 · strength 0.06
  15. Shinichi Egawa · 1 shared paper, 2018 · strength 0.06
  16. Hideaki Shimada · 1 shared paper, 2018 · strength 0.06
  17. Hidetoshi Eguchi · 1 shared paper, 2018 · strength 0.06
  18. Sadamu Homma · 1 shared paper, 2018 · strength 0.06
  19. Takeshi Ishikawa · 1 shared paper, 2018 · strength 0.06
  20. Hiroaki Nagano · 1 shared paper, 2018 · strength 0.06
  21. Sumiyuki Nishida · 1 shared paper, 2018 · strength 0.06
  22. Shigeo Koido · 1 shared paper, 2018 · strength 0.06
  23. Michiaki Unno · 1 shared paper, 2018 · strength 0.06
  24. Haruo Sugiyama · 1 shared paper, 2018 · strength 0.06
  25. Yousuke Michikawa · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.